Memantine Side Effects
>>>Help Community - Post Your Memantine Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Memantine Side Effects
Memantine Safety Reports reported to FDA
Total Memantine reports: 154.Memantine FDA safety alerts: No.
Reported deaths: 24 Reported hospitalizations: 103.
Take Memantine Side Effects Survey or Share Your Memantine Story.
Reported Memantine Side Effects: fall, condition aggravated, blood creatine phosphokinase increased, aspartate aminotransferase increased, cholelithiasis, agitation, depressed level of consciousness, dehydration, alanine aminotransferase increased, cerebral atrophy, anorexia.
More About Memantine.
If you have questions about Memantine, you can ask a Health Expert or Ask Patient Community about Memantine.
Showing 1-50 of 154 Next >
Memantine Side Effects Report #5067215-3Health Professional from UNITED KINGDOM reported MEMANTINE problem on July 10, 2006. Male patient, 70 years of age, was diagnosed with dementia alzheimer's type, analgesic effect and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: gaze palsy, muscle rigidity, musculoskeletal stiffness. MEMANTINE dosage: 5 MG BID PO. During the same period patient was treated with FENTANYL. Patient recovered.
Memantine Side Effects Report #5071848-8
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on July 12, 2006. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: partial seizures, status epilepticus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with OXAZEPAM, REMINYL, MELPERON, DURAZANIL, ATROVENT, TAMSULOSIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5071849-X
Consumer or non-health professional from GERMANY reported MEMANTINE problem on July 21, 2006. Male patient, 83 years of age, weighting 116.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, lumbar spinal stenosis. MEMANTINE dosage: unknown. During the same period patient was treated with INSULIN, MECOBALAMIN, LIMAPROST ALFADEX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5072876-9
MEMANTINE problem was reported by a Health Professional from JAPAN on July 21, 2006. Male patient, 83 years of age, weighting 116.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, gait disturbance. MEMANTINE dosage: unknown. During the same period patient was treated with INSULIN, MECOBALAMIN, LIMAPROST ALFADEX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5072877-0
Health Professional from GERMANY reported MEMANTINE problem on July 12, 2006. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: convulsion, status epilepticus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with OXAZEPAM, REMINYL, MELPERON, DURAZANIL, ATROVENT, TAMSULOSIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5072896-4
MEMANTINE problem was reported by a Health Professional from FRANCE on July 13, 2006. Male patient, 82 years of age, was diagnosed with dementia alzheimer's type, dysthymic disorder, atrial fibrillation, atrial flutter, cardiac failure and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: brain compression, cerebral haemorrhage, coagulation time prolonged, coma, international normalised ratio increased. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with EQUANIL, PREVISCAN, FUROSEMIDE, AMIODARONE, PAROXETINE. Patient died.
Memantine Side Effects Report #5077909-1
Consumer or non-health professional from GERMANY reported MEMANTINE problem on Aug 04, 2006. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: partial seizures, status epilepticus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with OXAZEPAM, REMINYL, MELPERON, DURAZANIL, ATROVENT, TAMSULOSIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5077910-8
MEMANTINE problem was reported by a Consumer or non-health professional from SPAIN on July 21, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5077921-2
Consumer or non-health professional from CANADA reported MEMANTINE problem on July 25, 2006. Male patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: fall. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DILANTIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5080131-6
MEMANTINE problem was reported by a Physician from UNITED STATES on Aug 07, 2006. Male patient, 84 years of age, weighting 185.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, cardiac failure. MEMANTINE dosage: unknown. During the same period patient was treated with ATENOLOL, ARICEPT, ALLOPURINOL, EC ASA, VITAMIN, TRAZODONE, EXTRA STRENGTH TYLENOL, SEROQUEL. Patient died on 05/25/2005.
Memantine Side Effects Report #5080133-X
Health Professional from GERMANY reported MEMANTINE problem on Aug 01, 2006. Female patient, 43 years of age, was diagnosed with depression and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hallucination, visual. MEMANTINE dosage: 10 MG QD. During the same period patient was treated with RILUZOLE, BUPROPION, LITHIUM, AMOXAPINE, TIAGABINE, DIAZEPAM. Patient recovered.
Memantine Side Effects Report #5082976-5
MEMANTINE problem was reported by a Health Professional from GERMANY on July 28, 2006. Female patient, 70 years of age, weighting 165.3 lb, was diagnosed with intentional overdose and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aspiration, atrioventricular block first degree, bradycardia, coma, intentional overdose. MEMANTINE dosage: 1000 MG ONCE PO. During the same period patient was treated with MELPERON, REMERON, VENLAFAXINE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5084557-6
Consumer or non-health professional from JAPAN reported MEMANTINE problem on July 31, 2006. Male patient, 63 years of age, weighting 159.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: retinal detachment, vitreous floaters, vitreous haemorrhage. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESTILATE, TELMISARTAN, CARBAZOCHROME SULFONATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5084559-X
MEMANTINE problem was reported by a Consumer or non-health professional from BELGIUM on July 06, 2006. Female patient, 86 years of age, was diagnosed with apathy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN CALCIUM, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5085078-7
Consumer or non-health professional from IRELAND reported MEMANTINE problem on Aug 02, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: agitation, balance disorder, confusional state, convulsion, hallucination, insomnia, paranoia, suicidal ideation. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SINEMET, CAPRIN, XATRAL. Patient recovered.
Memantine Side Effects Report #5088384-5
MEMANTINE problem was reported by a Pharmacist from JAPAN on Aug 17, 2006. Male patient, 63 years of age, weighting 159.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: retinal detachment, vitreous floaters, vitreous haemorrhage. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TELMISARTAN, CARBAZOCHROME SULFONATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5091911-5
Health Professional from GERMANY reported MEMANTINE problem on Aug 15, 2006. Male patient, 79 years of age, was diagnosed with dementia, agitation, sleep disorder and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: agitation, fall, pleurothotonus, sleep disorder. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE, PROTHIPENDYL, GLUCOBAY, PRAVASTATIN, METOPROLOL TARTRATE, CAPTOGAMMA. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5092834-8
MEMANTINE problem was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 82 years of age, weighting 101.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, cerebrovascular accident. MEMANTINE dosage: 28 MG QD. During the same period patient was treated with DONEPEZIL, NORVASC, FOLIC ACID. Patient was hospitalized. Patient died on 03/04/2006.
Memantine Side Effects Report #5093442-5
Health Professional from GERMANY reported MEMANTINE problem on Aug 17, 2006. Female patient, 70 years of age, weighting 165.3 lb, was diagnosed with intentional overdose and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aspiration, atrioventricular block first degree, blood creatine phosphokinase increased, bradycardia, coma, vomiting. MEMANTINE dosage: 1000 MG ONCE PO. During the same period patient was treated with MELPERON, REMERON, VENLAFAXINE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5096532-6
MEMANTINE problem was reported by a Health Professional from CANADA on Aug 14, 2006. Male patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: fall. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DILANTIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5100728-4
Health Professional from CANADA reported MEMANTINE problem on Aug 24, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, pancreatitis. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DIDROCAL, CALCIUM GLUCONATE, ACCUPRIL, NORVASC, HYDROCHLOROTHIAZIDE, PLAVIX, ARTHROTEC, TYLENOL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5102577-X
MEMANTINE problem was reported by a Health Professional from JAPAN on Aug 24, 2006. Male patient, 80 years of age, weighting 121.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: amnesia, condition aggravated, gait disturbance, lung disorder, pleurisy, pneumonia, tachycardia, wheezing. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with TOCOPHEROL NICOTINATE, UBIDECARENONE, NAFTOPIDIL, SENNOSIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5104106-3
Health Professional from JAPAN reported MEMANTINE problem on Aug 31, 2006. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arthritis, blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, somnolence. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODEOXYCHOLIC ACID, TERBINAFINE, BETAMETHASONE DIPROPIONATE, TIAPRIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5107766-6
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on Aug 29, 2006. Female patient, 70 years of age, weighting 165.3 lb, was diagnosed with intentional overdose and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aspiration, atrioventricular block first degree, blood creatine phosphokinase increased, bradycardia, c-reactive protein increased, coma, intentional overdose, vomiting. MEMANTINE dosage: 1000 MG ONCE PO. During the same period patient was treated with MELPERON, REMERON, VENLAFAXINE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5107768-X
Consumer or non-health professional from GERMANY reported MEMANTINE problem on Sept 07, 2006. Male patient, 80 years of age, weighting 121.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: amnesia, body height increased, condition aggravated, gait disturbance, hypoxia, lung disorder, pleural calcification, pyothorax, tachycardia. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with TOCOPHEROL NICOTINATE, UBIDECARRENONE, NAFTOPIDIL, SENNOSIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5110819-X
MEMANTINE problem was reported by a Health Professional from ITALY on Sept 14, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HALOPERIDOLE, ACEIL SALICILATE OF LYSINE, ENALAPRIL MALEATE. Patient was hospitalized and became disabled. Patient recovered.
Memantine Side Effects Report #5110836-X
Consumer or non-health professional from JAPAN reported MEMANTINE problem on Sept 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood cholinesterase decreased, blood creatine phosphokinase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #5116939-8
MEMANTINE problem was reported by a Consumer or non-health professional from CANADA on Sept 07, 2006. Male patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: fall. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DILANTIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5119996-8
Health Professional from SPAIN reported MEMANTINE problem on Sept 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5119997-X
MEMANTINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2006. Male patient, 63 years of age, weighting 159.8 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: retinal detachment, vitreous haemorrhage. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TELMISARTAN, CARBAZOCHROME SULFONATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5120001-8
Health Professional from BELGIUM reported MEMANTINE problem on Sept 26, 2006. Female patient, 86 years of age, weighting 180.8 lb, was diagnosed with apathy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5120002-X
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on Sept 12, 2006. Female patient, 60 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: disease recurrence, hypertensive crisis. MEMANTINE dosage: unknown. During the same period patient was treated with PALLADONE, ARCOXIA, LYRICA, CLOPIDOGREL BISULPHATE, TORSEMIDE, ENALAPRIL MALEATE, CORVATON, NEXIUM. Patient recovered.
Memantine Side Effects Report #5120003-1
Health Professional from JAPAN reported MEMANTINE problem on Sept 22, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, cough, depressed level of consciousness, diffuse large b-cell lymphoma stage iv. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #5121875-7
MEMANTINE problem was reported by a Consumer or non-health professional from SWEDEN on Sept 05, 2006. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, aggression, anxiety, arteriosclerosis, bladder pain, blood pressure immeasurable, bowel sounds abnormal, cardiovascular disorder, cerebral atrophy. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAND, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.
Memantine Side Effects Report #5121887-3
Health Professional from FRANCE reported MEMANTINE problem on Sept 18, 2006. Male patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrial flutter, blood sodium increased, c-reactive protein increased, consciousness fluctuating, fall, overdose, somnolence. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with HEPARIN CALCIUM, ARICEPT, SECTRAL, PERINDOPRIL ERBUMINE, LASIX, IKOREL, KARVEA HCT, ASPIRIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5121923-4
MEMANTINE problem was reported by a Health Professional from BELGIUM on Sept 04, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood uric acid decreased, cognitive disorder, depressed level of consciousness, diabetes mellitus inadequate control, disorientation, disturbance in social behaviour, dizziness, glycosylated haemoglobin increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAN, PANTOPRAZOLE, DIAMICRON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5127351-X
Health Professional from FRANCE reported MEMANTINE problem on Sept 22, 2006. Male patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: prostatic adenoma, urinary incontinence, urinary tract infection. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with EXELON. Patient recovered.
Memantine Side Effects Report #5130095-1
MEMANTINE problem was reported by a Health Professional from GERMANY on Oct 11, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5130733-3
Physician from UNITED STATES reported MEMANTINE problem on Oct 18, 2006. Male patient, weighting 140.0 lb, was diagnosed with dyskinesia, dystonia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, post concussion syndrome, rash erythematous, rash papular, rash pustular, stevens-johnson syndrome. MEMANTINE dosage: unknown. During the same period patient was treated with AMANTADINE. Patient recovered.
Memantine Side Effects Report #5135621-4
MEMANTINE problem was reported by a Physician from UNITED STATES on Oct 16, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5136716-1
Health Professional from AUSTRALIA reported MEMANTINE problem on Feb 06, 2003. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: pneumonia. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with FLIXOTIDE, ATROVENT, CEPHALEXIN, PREDNISONE, RISPERDAL, PANTOPRAZOLE, VENTOLIN, MORPHINE. Patient was hospitalized. Patient died on 12/24/2002.
Memantine Side Effects Report #5141674-X
MEMANTINE problem was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 88 years of age, weighting 114.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase decreased, anaemia, asthenia, blood amylase increased, brain natriuretic peptide increased, cardiac failure congestive, carotid artery atheroma, coronary artery insufficiency, dizziness. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, FOLIC ACID, MIRTAZAPINE, RISEDRONATE, DOCUSATE, RANITIDINE, TRIMETHOPRIM, DARVOCET. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5141871-3
Health Professional from CANADA reported MEMANTINE problem on Aug 24, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, pancreatitis. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DIDROCAL, CALCIUM, ACCUPRIL, NORVASC, HYDROCHLOROTHIAZIDE, PLAVIX, ARTHROTEC, TYLENOL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5141874-9
MEMANTINE problem was reported by a Consumer or non-health professional from ITALY on Oct 17, 2006. Female patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bradykinesia, hallucination, visual, muscle rigidity. MEMANTINE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BISPHOSPHONATE, DONEPEZIL, PAROXETINE, TRAZODONE, FOLIC ACID, VITAMIN E. Patient recovered.
Memantine Side Effects Report #5142876-9
Health Professional from GERMANY reported MEMANTINE problem on Oct 20, 2006. Male patient, 79 years of age, was diagnosed with dementia, agitation, sleep disorder and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: agitation, fall, pleurothotonus, restlessness, sleep disorder. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with REMINYL, DOMINAL, GLUCOBAY, PRAVASTATIN, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5142877-0
MEMANTINE problem was reported by a Health Professional from ITALY on Oct 24, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, ophthalmoplegia, strabismus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.
Memantine Side Effects Report #5144587-2
Health Professional from FRANCE reported MEMANTINE problem on Oct 16, 2006. Female patient, 82 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: disinhibition, hallucinations, mixed, renal failure. MEMANTINE dosage: unknown. During the same period patient was treated with EXELON. Patient recovered.
Memantine Side Effects Report #5144589-6
MEMANTINE problem was reported by a Health Professional from FRANCE on Oct 25, 2006. Male patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: escherichia infection, prostatitis, sepsis. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with IKOREL, ATENOL, PRAVASTATIN, EQUANIL. Patient recovered.
Memantine Side Effects Report #5146293-7
Health Professional from ITALY reported MEMANTINE problem on Oct 18, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, extraocular muscle paresis, fibrosis, gamma-glutamyltransferase increased, strabismus, ultrasound doppler abnormal. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.
Memantine Side Effects Report #5147144-7
MEMANTINE problem was reported by a Health Professional from JAPAN on Oct 27, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic carcinoma, weight decreased. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN, TERBINAFINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/22/2006.
Showing 1-50 of 154 Next >
Drug Information: Memantine
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a604006.html
mem'-an-teenWhy is this medication prescribed?
Memantine is used to treat the symptoms of Alzheimer's disease. Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal excitement in the brain. Memantine can help people with Alzheimer's disease to think more clearly and perform daily activities more easily, but it is not a cure and does not stop the progression of the disease.
How should this medicine be used?
Memantine comes as a tablet to take by mouth. It is usually taken once or twice a day with or without food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. To help you remember to take memantine, take it at around the same time(s) every day. Take memantine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor will probably start you on a low dose of memantine and gradually increase your dose, not more than once every week.
Memantine controls Alzheimer's disease but does not cure it. Continue to take memantine even if you feel well. Do not stop taking memantine without talking to your doctor.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking memantine,
- tell your doctor and pharmacist if you are allergic to memantine or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: acetazolamide (Diamox); amantadine (Symmetrel); brinzolamide (Azopt); cimetidine (Tagamet); dextromethorphan (Robitussin, others); dichlorphenamide (Daranide); dorzolamide (Trusopt); methazolamide (GlaucTabs, Nepatazane); nicotine (Nicoderm, Nicorette, others); potassium citrate and citric acid (Cytra-K, Polycitra-K); ranitidine (Zantac); sodium bicarbonate (Soda Mint, baking soda); sodium citrate and citric acid (Bicitra, Oracit); and quinidine (Quinaglute, Quinidex). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had asthma, seizures, kidney disease, or repeated urinary tract infections.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking memantine, call your doctor.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking memantine.
- you should know that memantine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
- tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.
What special dietary instructions should I follow?
Tell your doctor if you are a vegetarian or if you usually eat large amounts of citrus fruits, vegetables, beans, or peas. Your doctor will tell you if you need to change your diet. If you do not regularly eat these foods, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Memantine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- extreme tiredness
- dizziness
- confusion
- headache
- sleepiness
- constipation
- vomiting
- pain anywhere in your body, especially your back
- coughing
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:
- shortness of breath
- hallucination (seeing things or hearing voices that do not exist)
Memantine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- restlessness
- hallucination (seeing things or hearing voices that do not exist)
- sleepiness
- loss of consciousness
What other information should I know?
Keep all appointments with your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|